Yes / In recent years, the reports on using nonsteroidal anti-inflammatory drugs (NSAIDs)
for cancer prevention and treatment have been on the rise. In 2017, the US Preventive Services
Working Group issued primary prevention guidelines on the use of NSAIDs, especially aspirin,
for cardiovascular disease and colorectal cancer, and formally established the role and status of
aspirin in cancer prevention. However, the mechanism of NSAIDs on preventing cancer is still
not clear. In this paper, the progress of the application of NSAIDs, especially aspirin, in the
prevention and treatment of tumors in recent years is summarized, and new ideas and directions
for the follow-up study are also discussed.
| Identifer | oai:union.ndltd.org:BRADFORD/oai:bradscholars.brad.ac.uk:10454/16607 |
| Date | 15 October 2018 |
| Creators | Zhang, Z., Chen, F., Shang, Lijun |
| Source Sets | Bradford Scholars |
| Language | English |
| Detected Language | English |
| Type | Article, Published version |
| Rights | © 2018 Zhang et al. This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms. php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed., CC-BY-NC |
Page generated in 0.0021 seconds